Smith A G, Francis J E
MRC Toxicology Unit, Carshalton, Surrey, U.K.
Biochem J. 1993 Apr 1;291 ( Pt 1)(Pt 1):29-35. doi: 10.1042/bj2910029.
Iron overload causes inhibition of hepatic uroporphyrinogen decarboxylase (UROD) and uroporphyria in C57BL/10ScSn but not DBA/2 mice [Smith, Cabral, Carthew, Francis and Manson (1989) Int. J. Cancer 43, 492-496]. We have investigated the induction of uroporphyria in 12 inbred strains of mice 25 weeks after iron treatment (600 mg/kg) to determine if there was any correlation with the Ah locus. Under these conditions, inhibition of UROD occurred to varying degrees in Ahd mice (SWR and AKR) as well as nominally Ahb-1 (C57BL/6J, C57BL/10ScSn and C57BL/10-cc) and Ahb-2 strains (BALB/c and C3H/HeJ). Five other Ahb or Ahd strains (C57BL/Ks, A/J, CBA/J, LP and DBA/2) were unaffected. Thus there appeared to be no correlation with the Ah phenotype and this illustrated that some other variable inherited factors are involved. Comparisons between another susceptible strain, A2G, and the congenic A2G-hr/+strain (carrying the recessive hr gene) showed a modulating influence associated with the hr locus. In contrast with individual mice of inbred strains, which showed consistent responses to iron, those of the outbred MF1 strain showed a spectrum of sensitivities as might be expected for a heterogeneic stock. The rate of porphyria development was accelerated by administration of 5-aminolaevulinic acid (5-ALA) in the drinking water, but this did not overcome strain differences. Among four strains the order of susceptibility was SWR > C57BL/10ScSn > C57B1/6J > DBA/2 (the last strain was completely resistant). With degrees of iron loading greater than 600 mg of Fe/kg (1200-1800 mg of Fe/kg) C57BL/10ScSn mice (after 20 weeks) and SWR mice (after 5 weeks which included 4 weeks of 5-ALA treatment) had less inhibition of UROD and a lower uroporphyric response, showing that there was an optimum level of liver iron concentration. Studies on selected microsomal enzyme activities associated with cytochrome P-450 showed no correlation with the propensities of strains to develop porphyria. These activities included the NADPH-dependent oxidation of uroporphyrinogen I to uroporphyrin I.
铁过载会导致C57BL/10ScSn小鼠而非DBA/2小鼠的肝脏尿卟啉原脱羧酶(UROD)受到抑制并引发尿卟啉症[史密斯、卡布拉尔、卡休、弗朗西斯和曼森(1989年)《国际癌症杂志》43卷,492 - 496页]。我们研究了铁处理(600毫克/千克)25周后12个近交系小鼠中尿卟啉症的诱导情况,以确定是否与Ah位点存在任何关联。在这些条件下,Ahd小鼠(SWR和AKR)以及名义上的Ahb - 1(C57BL/6J、C57BL/10ScSn和C57BL/10 - cc)和Ahb - 2品系(BALB/c和C3H/HeJ)的UROD受到不同程度的抑制。其他五个Ahb或Ahd品系(C57BL/Ks、A/J、CBA/J、LP和DBA/2)未受影响。因此,似乎与Ah表型没有关联,这表明涉及一些其他可变的遗传因素。另一个易感品系A2G与同基因A2G - hr/+品系(携带隐性hr基因)之间的比较显示,hr位点具有调节作用。与近交系小鼠个体对铁表现出一致反应不同,远交系MF1品系的小鼠表现出一系列敏感性,这是异质种群所预期的。通过在饮用水中给予5 - 氨基酮戊酸(5 - ALA)可加速卟啉症的发展速度,但这并未克服品系差异。在四个品系中,易感性顺序为SWR > C57BL/10ScSn > C57B1/6J > DBA/2(最后一个品系完全抗性)。当铁负荷量大于600毫克铁/千克(1200 - 1800毫克铁/千克)时,C57BL/10ScSn小鼠(20周后)和SWR小鼠(5周后,其中包括4周的5 - ALA处理)的UROD抑制作用较小,尿卟啉症反应较低,表明存在肝脏铁浓度的最佳水平。对与细胞色素P - 450相关的选定微粒体酶活性的研究表明,与品系发生卟啉症的倾向没有关联。这些活性包括尿卟啉原I依赖NADPH氧化为尿卟啉I。